Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Myopia and Presbyopia Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence Pvt Ltd Product code 921265
Published Content info 113 Pages
Delivery time: 2-3 business days
Back to Top
Myopia and Presbyopia Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
Published: August 1, 2020 Content info: 113 Pages

The Myopia and Presbyopia Treatment Market is expected to witness a CAGR of 4.25% during the forecast period. The market for myopia and presbyopia is currently growing with a healthy rate which is majorly associated with the rising number of people suffering from vision impairment and the rapid growth in geriatric population across the globe.

The prevalence of vision impairment issues such as myopia is increasing globally at an alarming rate, with significant increases in the risks for vision impairment from pathologic conditions associated with high myopia, including retinal damage, cataract, and glaucoma. These diseases are causing elevation in the incidence of visual impairment in the people, due to which the demand for the treatment options, like contact lens, concave lens, or prescription lenses, have increased a lot across the world.

In addition, the government of the various countries are focusing on improvement of the patient flow for which they are also considering to increase the number eye clinics. The increasing eye clinics are augmenting the rise in procedural volume of eye surgeries which is a favourable factor for the market studied.

Key Market Trends

Myopia is Expected to Hold Significant Market Share in the Disease Type Segment

There are various factors responsible for the rising cases of myopia and some of them are reduced time spent outdoors, increased near work and increased rates of urbanization, among other factors. The rising geriatric population across the globe and the fact that the prevalence of vision impairment and many eye conditions increases in older age, will also lead to a substantial increase in the number of people that need eye care globally which will supplement the growth of the market.

Furthermore the annual global costs of productivity losses associated with vision impairment from uncorrected myopia alone were estimated to be USD 244 billion, as per the World Report On Vision 2019 published by World Health Organization. There are alos several treatment options available that effectively correct the blurred vision caused by myopia and some of them are corrective lenses and refractive surgery. Thus, considering the rising cases of myopia the market is expected to witness high growth over the forecast period.

North America Dominates the Market and is Expected to do Same in the Forecast Period

North America is the region with largest market share and Asia-Pacific is witnessing the fastest growth. Developed healthcare infrastructure and availability of advanced treatment options in the North America region are augmenting the growth of the market studied.

The growth of the market is also attributed due to the presence of various key market players, increasing people with myopia and presbyopia and high adoption of contact lens, contact lenses and surgery as the treatments in the region. Moreover the recent product launches, growing number of optometrists and increasing awareness regarding available treatment options are fueling the market growth.

Competitive Landscape

The global Myopia and Presbyopia Treatment market is highly competitive and consists of a number of major players. Companies like ALCON Inc., Bausch Health Companies Inc, Johnson & Johnson Vision, Topcon Corporation, Zeimer Ophthalmic Systems AG, among others, hold the substantial market share in the Myopia and Presbyopia Treatment market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 67118



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Cases of Vision Impairment
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Early Diagnosis
    • 4.3.2 High Cost of Treatment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Disease Type
    • 5.1.1 Myopia
    • 5.1.2 Presbyopia
  • 5.2 By Treatment Type
    • 5.2.1 Prescription Lenses
    • 5.2.2 Contact Lenses
    • 5.2.3 Surgery
    • 5.2.4 Medication
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 ALCON Inc
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 Essilor Luxottica (Essilor Ltd.)
    • 6.1.4 Johnson & Johnson Vision
    • 6.1.5 NIDEK CO. LTD.
    • 6.1.6 Topcon Corporation
    • 6.1.7 Zeimer Ophthalmic Systems AG
    • 6.1.8 Carl Zeiss Meditec AG


Back to Top